Mariner
OCUL icon

Mariner’s Ocular Therapeutix OCUL Stock Holding History

Mariner’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$108K Buy
+12,782
New +$122K ﹤0.01% 3313

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Mariner's OCUL Position: Q1 2026 in Review

Mariner opened a new position in Ocular Therapeutix (OCUL) in Q1 2026: 12,782 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #3313 among its holdings.

269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • Mariner held 12,782 shares of Ocular Therapeutix worth $108K as of Q1 2026.
  • Ocular Therapeutix was a new Mariner position in Q1 2026.
  • Ocular Therapeutix made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #3313 holding.
  • 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.